About Artms inc
Artms Inc: Revolutionizing the Production of Critical Isotopes for Patient Care
Artms Inc is a leading innovator in the field of medical isotopes, providing cutting-edge technology and solutions to meet the growing demand for critical isotopes used in patient care. The company's mission is to expand the reach and increase cyclotron production of large volumes of essential isotopes that are vital to the future of patient care.
With over a decade of experience in developing innovative technologies, Artms has become a trusted partner for hospitals, research institutions, and pharmaceutical companies worldwide. The company's flagship product, QUANTM Irradiation System™ (QIS), is a game-changer in medical isotope production.
The QIS system uses proprietary technology that enables hospitals and research institutions to produce their own medical isotopes on-site using existing cyclotron infrastructure. This eliminates the need for costly transportation and storage logistics associated with traditional centralized production methods.
Artms' QIS system also offers significant advantages over traditional methods by reducing waste generation, increasing efficiency, and improving safety. The system can produce multiple isotopes simultaneously with high yields while minimizing radiation exposure risks to operators.
The company's commitment to innovation has led to several partnerships with leading organizations such as GE Healthcare, TRIUMF Innovations, and Advanced Cyclotron Systems Inc., among others. These collaborations have resulted in groundbreaking advancements in medical isotope production that have revolutionized patient care worldwide.
Artms' dedication to quality assurance ensures that all products meet or exceed regulatory requirements set by international bodies such as Health Canada and the US Food & Drug Administration (FDA). This commitment has earned Artms ISO 13485 certification for its quality management systems related to medical devices.
In addition to its core business operations focused on medical isotope production solutions, Artms also provides consulting services related to nuclear medicine facility design optimization. These services help clients optimize their facilities' design layout while ensuring compliance with regulatory requirements.
Artms' team of experts comprises experienced professionals in the fields of nuclear medicine, engineering, and business development. The company's leadership team includes CEO Doug Beynon, who has over 25 years of experience in the medical device industry, and CTO Dr. Paul Schaffer, a renowned expert in medical isotope production.
In conclusion, Artms Inc is a leading innovator in the field of medical isotopes that provides cutting-edge technology and solutions to meet the growing demand for critical isotopes used in patient care. The company's flagship product, QUANTM Irradiation System™ (QIS), is a game-changer that enables hospitals and research institutions to produce their own medical isotopes on-site using existing cyclotron infrastructure. With its commitment to innovation and quality assurance, Artms has become a trusted partner for hospitals, research institutions, and pharmaceutical companies worldwide.